What is Fast to Proof-of-Concept?

What’s the Structure?  

The structure is a light, adaptable, but targeted approach. The awareness and ability to adapt to our clients’ needs and processes is critical. We’re deliberate in assembling small, bespoke teams of designers and engineers with proven track records to rapidly synthesize data and convert those needs into actionable and impactful solutions – often against wildly aggressive timelines. These timelines can be as little as four weeks. For our clients, this is a relatively small investment in time and capital that dramatically reduces risk and positions them safely on a product development pathway.  

Who Benefits?  

Every client is different. Their needs, timelines, budgets, and processes are always unique. Regardless of their scale and resources, large capital or startup, being able to explore, embody, and vet conceptual solutions quickly and with confidence can be one of the biggest determining factors of whether a product or approach will be successful. “Fail fast” is a common saying, but “succeed fast,” is the goal.  

Why is it Successful?  

At a high level, going this route de-risks a concept to a point of confidence before the client needs to fully commit resources to a development effort. This process allows clients to:  

• Test and measure the value and impact of proposed solutions rapidly and at a reasonable investment 

• Develop and refine IP to protect their positions 

• Develop solution resolution to gain funding and internal alignment  

• Achieve rapid development that is otherwise unattainable within internal structures 

• Reach rapid device optimization  

Our Capabilities  

We have a strong core team with an established and profound internal expertise and passion to execute against the market need of fast to proof-of-concept. Our design engineers and industrial designers have the experience to execute rapidly and with minimal resources to a high degree of success and are well-connected and respected resources within the medtech, medical device and overarching life science industry. Plus, our track record speaks for itself – last year, this group had a 90%+ continuation or multiple continuation rate.